Health Watch Table
(Printable PDF version can be found at the bottom)
(Includes DiGeorge Syndrome (DGS), Velocardiofacial Syndrome (VCFS), Shprintzen Syndrome, Conotruncal Anomaly Face Syndrome (CTAF), Caylor Cardiofacial Syndrome, and Autosomal Dominant Opitz G/BBB Syndrome)
Considerations | Recommendations |
1. Head, eyes, ears, nose, throat | |
|
|
2. Dental | |
|
|
3. Cardiovascular | |
|
|
4. Respiratory | |
|
|
Adults: In order of prevalence, there is an increased frequency of recurrent pneumonia, atelectasis, asthma, and chronic obstructive pulmonary disease | Consider periodic pulmonary function studies and referral to a pulmonologist as warranted by clinical findings |
5. Sleep | |
Children: Congenital malformations may lead to airway obstructions and obstructive sleep apnea (OSA) | Undertake a sleep study in infancy and then as warranted by clinical findings after 3 years of age |
Adults: Those with uncorrected congenital malformations remain at risk for OSA | Undertake a sleep study as warranted by clinical findings |
6. Gastrointestinal | |
|
|
7. Genitourinary | |
|
|
8. Sexual function | |
Children and Adults: People with the 22q11.2 deletion syndrome are fertile and have a 50% chance of transmitting the 22q11.2 deletion to children | Referral for genetic counseling may be appropriate |
9. Musculoskeletal | |
|
|
10. Neurological | |
|
|
11. Behavioral / mental health | |
|
|
12. Endocrine | |
~ 4% have growth hormone deficiency ~ 35% of adults are obese ~ 20% of adults have hypothyroidism ~ 5% of adults have hyperthyroidism |
|
13. Hematological | |
|
|
14. Infectious disease/immunization | |
|
|
15. Dermatological | |
|
|
16. Other | |
|
Original tool: © 2011 Surrey Place Centre.
Developed by Forster-Gibson C, Berg J, & Developmental Disabilities Primary Care Initiative Co-editors.
Expert Clinician Reviewer
Thanks to the following clinician for her review and helpful suggestions:
Anne Bassett, MD
Director, Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto
Canada Research Chair, Schizophrenia Genetics
Modified with permission of Surrey Place Centre. This tool was reviewed and adapted for U.S. use by physicians on the Toolkit’s Advisory Committee.
Modified with permission of Surrey Place Centre. This tool was reviewed and adapted for U.S. use by physicians on the Toolkit’s Advisory Committee.
Resources
- 10 published 22q11.2 deletion syndrome health care guidelines were reviewed and compared. For the full list of references, see the Surrey Place 22q11.2 Deletion Syndrome Health Watch Table . Accessed August 2025.
- 22q11.2 Deletion syndrome websites that may be helpful for families and caregivers
- Chromosome 22 Central. Accessed August 2025.
- International 22q11.2 Foundation. Accessed August 2025.
References
- Sullivan WF, Berg JM, Bradley E, Cheetham T, Denton R, Heng J, Hennen B, Joyce D, Kelly M, Korossy M, Lunsky Y, McMillan S. Primary care of adults with developmental disabilities: Canadian consensus guidelines. Can Fam Physician 2011;57:541-53.
- Weinzimer SA. Endocrine aspects of the 22q11.2 deletion syndrome. Genet Med 2001 Jan-Feb;3(1):19-22.
- Bassett AS, Chow EW, Husted J, Weksberg R, Caluseriu O, Webb GD, et al. Clinical features of 78 adults with 22q11 Deletion Syndrome. Am J Med Genet A 2005 Nov 1;138(4):307-13.
- Bassett AS. McDonald-McGinn DM. Devriendt K. Digilio MC. Goldenberg P. Habel A. Marino B. Oskarsdottir S. Philip N. Sullivan K. Swillen A. Vorstman J. International 22q11.2 Deletion Syndrome Consortium. Practical Guidelines for Managing Patients with 22q11.1 Deletion Syndrome. Journal of Pediatrics. 2011 Aug.; 159(2):332-9.e1..
- National Center for Biotechnology Information. Gene Reviews/22q11.2 Deletion Syndrome. Available at: www.ncbi.nlm.nih.gov/books/NBK1523/ Accessed August 2025.